Patents Assigned to Hyglos Invest GmbH
  • Publication number: 20140065104
    Abstract: The present invention relates to a polypeptide termed ply_pitti26 comprising the sequence as depicted in SEQ ID NO:1 as well as variants of this polypeptide. Furthermore, the present invention relates to nucleic acids and vectors encoding for said polypeptide and variants thereof as well as host cells comprising these nucleic acids and/or vectors. Finally, the present invention relates to the uses of said polypeptide, variants thereof, nucleic acid sequences, vectors and host cells, in particular for the treatment or prophylaxis of a subject infected by or exposed to Staphylococci.
    Type: Application
    Filed: September 9, 2013
    Publication date: March 6, 2014
    Applicant: Hyglos Invest GmbH
    Inventors: Michael FORCHHEIM, Holger GRALLERT, Anja PHILIPP, Manfred BIEBL
  • Publication number: 20130288926
    Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonisation and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.
    Type: Application
    Filed: June 17, 2011
    Publication date: October 31, 2013
    Applicant: HYGLOS INVEST GMBH
    Inventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger
  • Patent number: 8557519
    Abstract: The present invention relates to a polypeptide termed ply_pitti26 comprising the sequence as depicted in SEQ ID NO:1 as well as variants of this polypeptide. Furthermore, the present invention relates to nucleic acids and vectors encoding for said polypeptide and variants thereof as well as host cells comprising these nucleic acids and/or vectors. Finally, the present invention relates to the uses of said polypeptide, variants thereof, nucleic acid sequences, vectors and host cells, in particular for the treatment or prophylaxis of a subject infected by or exposed to Staphylococci.
    Type: Grant
    Filed: October 19, 2011
    Date of Patent: October 15, 2013
    Assignee: Hyglos Invest GmbH
    Inventors: Michael Forchheim, Holger Grallert, Anja Philipp, Manfred Biebl
  • Patent number: 8551719
    Abstract: The invention relates to a method for detecting endotoxins in a sample.
    Type: Grant
    Filed: February 20, 2013
    Date of Patent: October 8, 2013
    Assignee: Hyglos Invest GmbH
    Inventors: Roman Meyer, Michael Schütz, Holger Grallert, Renate Grassl, Stefan Miller
  • Publication number: 20130244224
    Abstract: The invention relates to a method for detecting endotoxins in a sample.
    Type: Application
    Filed: February 20, 2013
    Publication date: September 19, 2013
    Applicant: HYGLOS INVEST GMBH
    Inventors: Roman MEYER, Michael SCHÜTZ, Holger GRALLERT, Renate GRASSL, Stefan MILLER
  • Patent number: 8492519
    Abstract: The present invention relates to a modified polypeptide with a biological activity to lyse cell walls of bacteria, wherein the polypeptide has no caspase, clostripain, enterokinase, factor Xa, granzyme B, staphylococcus peptidase I (V8 Protease), plasmin, streptopain, bacillolysin and/or thrombin cleavage site. The invention further relates to nucleic acids with a sequence encoding a polypeptide according to the present invention.
    Type: Grant
    Filed: August 19, 2008
    Date of Patent: July 23, 2013
    Assignees: Hyglos Invest GmbH, bioMérieux S.A.
    Inventors: Holger Grallert, Michael Forchheim
  • Publication number: 20130183689
    Abstract: The present invention relates to bacteriophage tail proteins and the derivatives and fragments thereof that are capable of binding endotoxins in the absence of bivalent positive ions, especially Ca2+ or Mg2+. Further, the present invention relates to methods for depleting endotoxins from solutions and samples using the bacteriophage tail proteins according to the present invention and to a detection method for endotoxins.
    Type: Application
    Filed: November 21, 2012
    Publication date: July 18, 2013
    Applicant: HYGLOS INVEST GMBH
    Inventor: HYGLOS INVEST GMBH
  • Patent number: 8394597
    Abstract: The invention relates to a method for detecting endotoxins in a sample.
    Type: Grant
    Filed: December 20, 2004
    Date of Patent: March 12, 2013
    Assignee: Hyglos Invest GmbH
    Inventors: Roman Meyer, Michael Schütz, Holger Grallert, Renate Grassl, Stefan Miller
  • Patent number: 8329393
    Abstract: The present invention relates to bacteriophage tail proteins and the derivatives and fragments thereof that are capable of binding endotoxins in the absence of bivalent positive ions, especially Ca2+ or Mg2+. Further, the present invention relates to methods for depleting endotoxins from solutions and samples using the bacteriophage tail proteins according to the present invention and to a detection method for endotoxins.
    Type: Grant
    Filed: July 12, 2011
    Date of Patent: December 11, 2012
    Assignee: Hyglos Invest GmbH
    Inventors: Stefan Miller, Roman Meyer, Renate Grassl, Manfred Biebl, Holger Grallert
  • Publication number: 20120171188
    Abstract: The present invention relates to recombinant polypeptides having the activity of binding and lysing of bacteria, comprising at least one enzymatically active domain and at least two bacterial cell binding domains. The present invention further relates to recombinant polypeptide having the activity of binding bacteria, comprising at least two bacterial cell binding domain. Further the present inventions relates to nucleic acid molecules comprising a nucleotide sequence encoding the recombinant polypeptides, vectors and host cells.
    Type: Application
    Filed: October 3, 2011
    Publication date: July 5, 2012
    Applicants: HYGLOS INVEST GMBH, BIOMERIEUX S.A
    Inventors: Martin Loessner, Mathias Schmelcher, Holger Grallert, Falko Bretfeld
  • Publication number: 20120164126
    Abstract: The present invention relates to a polypeptide termed ply_pitti26 comprising the sequence as depicted in SEQ ID NO:1 as well as variants of this polypeptide. Furthermore, the present invention relates to nucleic acids and vectors encoding for said polypeptide and variants thereof as well as host cells comprising these nucleic acids and/or vectors. Finally, the present invention relates to the uses of said polypeptide, variants thereof, nucleic acid sequences, vectors and host cells, in particular for the treatment or prophylaxis of a subject infected by or exposed to Staphylococci.
    Type: Application
    Filed: October 19, 2011
    Publication date: June 28, 2012
    Applicant: HYGLOS INVEST GMBH
    Inventors: Michael Forchheim, Holger Grallert, Anja Philipp, Manfred Biebl
  • Publication number: 20110306068
    Abstract: The present invention relates to bacteriophage tail proteins and the derivatives and fragments thereof that are capable of binding endotoxins in the absence of bivalent positive ions, especially Ca2+ or Mg2+. Further, the present invention relates to methods for depleting endotoxins from solutions and samples using the bacteriophage tail proteins according to the present invention and to a detection method for endotoxins.
    Type: Application
    Filed: July 12, 2011
    Publication date: December 15, 2011
    Applicant: HYGLOS INVEST GMBH
    Inventors: Stefan Miller, Roman Meyer, Renate Grassl, Manfred Biebl, Holger Grallert
  • Patent number: 8058225
    Abstract: The present invention relates to a polypeptide termed ply_pitti26 comprising the sequence as depicted in SEQ ID NO:1 as well as variants of this polypeptide. Furthermore, the present invention relates to nucleic acids and vectors encoding for said polypeptide and variants thereof as well as host cells comprising these nucleic acids and/or vectors. Finally, the present invention relates to the uses of said polypeptide, variants thereof, nucleic acid sequences, vectors and host cells, in particular for the treatment or prophylaxis of a subject infected by or exposed to Staphylococci.
    Type: Grant
    Filed: August 19, 2008
    Date of Patent: November 15, 2011
    Assignee: Hyglos Invest GmbH
    Inventors: Michael Forchheim, Holger Grallert, Anja Philipp, Manfred Biebl
  • Patent number: 8003313
    Abstract: The present invention relates to bacteriophage tail proteins and the derivatives and fragments thereof that are capable of binding endotoxins in the absence of bivalent positive ions, especially Ca2+ or Mg2+. Further, the present invention relates to methods for depleting endotoxins from solutions and samples using the bacteriophage tail proteins according to the present invention and to a detection method for endotoxins.
    Type: Grant
    Filed: January 23, 2006
    Date of Patent: August 23, 2011
    Assignee: Hyglos Invest GmbH
    Inventors: Stefan Miller, Roman Meyer, Renate Grassl, Manfred Biebl, Holger Grallert
  • Publication number: 20110053188
    Abstract: The invention relates to a method for detecting endotoxins in a sample.
    Type: Application
    Filed: December 20, 2004
    Publication date: March 3, 2011
    Applicant: HYGLOS INVEST GMBH
    Inventors: Roman Meyer, Michael Schütz, Holger Grallert, Renate Grassl, Stefan Miller
  • Patent number: 7868144
    Abstract: The present invention relates to a method for unspecific enrichment of bacterial cells by means of cationic or anionic polymers and magnetic carriers.
    Type: Grant
    Filed: October 8, 2002
    Date of Patent: January 11, 2011
    Assignee: Hyglos Invest GmbH
    Inventors: Sabine Diller, Renate Grassl, Stefan Miller, Ingrid Robl, Michael Schütz, Thomas Zander
  • Patent number: 7858299
    Abstract: The invention relates to a method for identifying endotoxins for eliminating said endotoxins from a sample, with the aid of bacteriophage tail proteins.
    Type: Grant
    Filed: July 28, 2009
    Date of Patent: December 28, 2010
    Assignee: Hyglos Invest GmbH
    Inventors: Michael Schütz, Roman Meyer, Holger Grallert, Stefan Miller
  • Publication number: 20100047895
    Abstract: The present invention relates to a method for the selective purification of bacterial cells and/or cell components, whereby the purification is performed by means of a solid support.
    Type: Application
    Filed: July 28, 2009
    Publication date: February 25, 2010
    Applicants: Hyglos Invest GmbH, bioMerieux S.A.
    Inventors: Michael Schütz, Renate Grassl, Roman Meyer, Sibylle Frick, Ingrid Robl, Thomas Zander, Stefan Miller